Invesco Ltd. (IVZ) — Fair Value Analysis

Base-case fair value (P50): $3.90 · Current price: $27.01 · Verdict: Overvalued

The Verdict on IVZ

Invesco (IVZ) is currently rated as Deeply Overvalued based on our comprehensive Monte Carlo simulations. With a current market price of $27.01, IVZ significantly exceeds our median fair value (P50) of $3.90. This stark contrast implies a substantial -85.6%, indicating the stock faces considerable downside risk from its current levels. Our analysis, which models thousands of forward scenarios, suggests that investors are paying a premium well beyond fundamental support for IVZ at $27.01.

How IVZ stacks up against Financial Services

Within the Financial Services sector, Invesco (IVZ) currently holds an "unrated" quality tier, meaning its operational and financial health against sector peers is not currently assessed. This unrated status, combined with a significant divergence between its $27.01 and a fair value of $3.90, presents a challenging picture. The large -85.6% highlights that the market’s current valuation of $27.01 is not aligned with the intrinsic value derived from our probabilistic models for a company with an unrated quality profile in this competitive sector.

What this means for investors

For investors considering Invesco (IVZ), the "Deeply Overvalued" verdict and the substantial -85.6% derived from our Monte Carlo simulations suggest caution. The current price of $27.01 is dramatically higher than the median fair value of $3.90, indicating a high probability of mean reversion. While a bull case scenario may exist, the current valuation implies significant headwinds, particularly given the unrated quality tier. To fully understand the distribution of outcomes, including bear and bull targets, and to track IVZ's fair value as new fundamentals are released, sign up for a free FairCurve account.